A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and develop new treatments, diagnostics, and preventative methods for specific and complex conditions.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: t
View:

• Persons 18 to 85 years of age at the date of informed consent.

• If presenting with a history of a specific condition, the diagnosis is confirmable in the medical record or may be confirmed using other forms of verification including self-reporting.

• Understands the procedures and requirements of the study by providing written informed consent (or verbal assent if a legally authorized representative will sign the ICF), including consent for authorization for protected health information disclosure.

Locations
United States
Massachusetts
Sanguine Biosciences
RECRUITING
Waltham
Contact Information
Primary
Carolyn Bidwell
study@sanguinebio.com
855.836.4759
Time Frame
Start Date: 2021-10-26
Estimated Completion Date: 2025-10
Participants
Target number of participants: 20000
Treatments
Health Condition Group
Exceptive Condition Group
Control Group
Sponsors
Leads: Sanguine Biosciences

This content was sourced from clinicaltrials.gov